Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | ONCOLOGY//CELL BIOLOGY//BIOCHEMISTRY & MOLECULAR BIOLOGY | 2934640 |
196 | 3 | LUNG CANCER//NON SMALL CELL LUNG CANCER//THORAC SURG | 53631 |
2113 | 2 | CRIZOTINIB//ALK//ANAPLASTIC LYMPHOMA KINASE | 5482 |
21842 | 1 | RESEARCH BIOPSY//PRECISION ONCOLOGY//PERSONALIZED CANC THER Y | 427 |
Terms with highest relevance score |
rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|---|
1 | RESEARCH BIOPSY | authKW | 670989 | 2% | 91% | 10 |
2 | PRECISION ONCOLOGY | authKW | 507856 | 4% | 40% | 17 |
3 | PERSONALIZED CANC THER Y | address | 394239 | 6% | 21% | 25 |
4 | MOLECULAR TUMOR BOARD | authKW | 230649 | 1% | 63% | 5 |
5 | PRECISION CANCER MEDICINE | authKW | 205020 | 1% | 56% | 5 |
6 | PRECISION MEDICINE | authKW | 194862 | 10% | 6% | 44 |
7 | GENOTYPE DIRECTED THERAPY | authKW | 147618 | 0% | 100% | 2 |
8 | PHARMACOLOGICAL AUDIT TRAIL | authKW | 147618 | 0% | 100% | 2 |
9 | INVEST CANC THER EUT | address | 138270 | 6% | 7% | 27 |
10 | ACTIONABLE MUTATION | authKW | 132854 | 1% | 60% | 3 |
Web of Science journal categories |
chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | Oncology | 6231 | 62% | 0% | 265 |
2 | Pathology | 137 | 6% | 0% | 24 |
3 | Medicine, Research & Experimental | 105 | 7% | 0% | 30 |
4 | Genetics & Heredity | 101 | 8% | 0% | 33 |
5 | Cell Biology | 90 | 9% | 0% | 40 |
6 | Medical Laboratory Technology | 85 | 3% | 0% | 11 |
7 | Medical Informatics | 62 | 2% | 0% | 7 |
8 | Pharmacology & Pharmacy | 39 | 8% | 0% | 35 |
9 | Health Care Sciences & Services | 33 | 2% | 0% | 10 |
10 | Information Science & Library Science | 15 | 1% | 0% | 5 |
Address terms |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | PERSONALIZED CANC THER Y | 394239 | 6% | 21% | 25 |
2 | INVEST CANC THER EUT | 138270 | 6% | 7% | 27 |
3 | CLIN TRIAL MANAGEMENT UNIT | 98411 | 0% | 67% | 2 |
4 | KHALIFA PERSONALIZED CANC THER Y | 98411 | 0% | 67% | 2 |
5 | ONCOL TRANSLAT SCI | 98411 | 0% | 67% | 2 |
6 | INSERM UNIT U981 | 98407 | 1% | 33% | 4 |
7 | AMMICA | 94894 | 1% | 43% | 3 |
8 | ALBACETE FDN HOSP NACL PAR LEJICOS | 73809 | 0% | 100% | 1 |
9 | BIOMARKERS COUNCIL | 73809 | 0% | 100% | 1 |
10 | BIOMED AMER | 73809 | 0% | 100% | 1 |
Journals |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | NATURE REVIEWS CLINICAL ONCOLOGY | 15618 | 2% | 2% | 10 |
2 | GENOME MEDICINE | 6675 | 2% | 1% | 8 |
3 | PERSONALIZED MEDICINE | 6479 | 2% | 1% | 7 |
4 | MOLECULAR ONCOLOGY | 5696 | 2% | 1% | 8 |
5 | JAMA ONCOLOGY | 5668 | 1% | 2% | 5 |
6 | CURRENT PROBLEMS IN CANCER | 5354 | 1% | 1% | 5 |
7 | ONCOLOGIST | 4553 | 3% | 1% | 12 |
8 | CURRENT OPINION IN ONCOLOGY | 4148 | 2% | 1% | 9 |
9 | CANCER DISCOVERY | 3539 | 1% | 1% | 5 |
10 | JOURNAL OF CLINICAL ONCOLOGY | 3008 | 6% | 0% | 26 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |